Cefmenoxime hemihydrochloride is a third-generation cephalosporin antibiotic used clinically for the treatment of infections caused by susceptible bacteria, including respiratory tract infections, hepatobiliary infections, urinary and genital infections, peritonitis, and postoperative infections. It is particularly effective against Gram-negative bacteria, especially Klebsiella pneumoniae, due to its high stability against β-lactamases, strong affinity for penicillin-binding proteins (PBPs 1A, 1B, and 3), and excellent penetration through the bacterial outer membrane. It is commonly administered as an injectable formulation (intravenous or intramuscular) and has been widely applied in the treatment of lobar pneumonia in children.